# Affluent Medical to acquire Caranx Medical and Artedrone, become Carvolix

Affluent Medical entered binding agreements to acquire Caranx Medical and Artedrone for €16.6M and €11.4M respectively, paid in shares. The combined entity will be named Carvolix, focusing on cardiovascular therapies with AI-driven mini-robots and implants.

- Type: Acquisition
- Announced: 2025-12-19
- Where: Aix-en-Provence, France
- Value: $30.0M (28.0M EUR)
- Status: announced
- Products: cardiovascular implants, AI-driven autonomous mini-robots, TAVIPILOT Software
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Affluent Medical](https://endata.com/companies/78572.md) (acquirer)
- [Caranx Medical](https://endata.com/companies/89279.md) (target)
- [Artedrone](https://endata.com/companies/89280.md) (target)
- [Carvolix](https://endata.com/companies/89281.md) (partner)

## Sources

- [tradingview.com](https://www.tradingview.com/news/eqs:fada6864f094b:0-affluent-medical-announces-upcoming-acquisition-of-caranx-medical-and-artedrone-becoming-carvolix-pioneering-cardiovascular-therapies/), 2025-12-19: "Affluent Medical announces upcoming acquisition of Caranx Medical and Artedrone, becoming Carvolix, pioneering cardiovascular therapies with AI driven autonomous mini-robots and innovative implants."
- [massdevice.com](https://www.massdevice.com/affluent-medical-acquire-caranx-artedrone/), 2025-12-22: "We're applying the proven business builder model — uniting the capabilities of Truffle-founded companies to de-risk development, accelerate innovation, and unlock value for shareholders."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.